Trial
NCT01316523
Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's Lymphoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, Davis
Collaborators
Celgene
Condition
Non Hodgkin's Lymphoma
Intervention
Rituximab
Why stopped
Sponsor choice
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-21